I was recently contacted about participating in a trial for the Viking Therapeutics drug VK0214-102, which is a potential treatment for AMN. Apparently they are looking for 36 participants around the country. I am not sure yet whether I will be able to participate in this study, but I'm wondering if anyone else in this group has been contacted about participating?
Viking Therapeutics drug VK0214-102: I was... - AMN EASIER
Viking Therapeutics drug VK0214-102
This is the new drug in the pipeline that was announced at the virtual conference: new oral small molecule to treat adrenoleukodystrophy which is a novel small molecule agonist of the thyroid hormone. I remembered the keyword molecule. They just received FDA approval. I'm back with Min-102 using the drug which is to be completed in 2023.
Are you on the MIN-102 trial? I presume you can't do both at the same time
I was on the list for that at the Kennedy Krieger location in Baltimore Maryland where are you located for the trial
How do I learn more?
Nope, but am always open to this kind of thing.
I have not been contacted but may be due to already participating in MIN-102. I’d be willing to hear more about it to make an educated decision which is more promising.
I am interested in how you all were notified or became aware of MIN-102 and if that same channel was used for the Viking trial. Please share your insights, Thanks!
Any more news on this clinical study? My geneticist gave me info on it today.
Hi, Coslet. Right now I’m taking part in Viking medical trials in Seattle, Washington. As I know they still looking for AMN people how will suit this trial.
How has it gone? I’m still contemplating sighing up.
Nothing unusual, staying at home 90% of time, taking pills. If you need I can ask email of coordinator for you.